Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06733662

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

This randomized controlled trial will be conducted to evaluate the effect of education and motivational interviewing on treatment adherence and self-care power in COPD patients.

Hypotheses of the Study; H1: Education and motivational interviewing in COPD patients increase treatment adherence in patients.

H2: Education and motivational interviewing in COPD patients increase self-care power in patients.

There will be two groups in the study: control and intervention groups. Before the intervention, pre-test data will be collected in the control and intervention groups. After the intervention, post-test data will be collected in both groups in line with the data collection forms.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kahramanmaraş Istiklal Universty

Kahramanmaraş, Turkey (Türkiye)

Location status: Recruiting

Location contact

Meltem KALAYCI

SUB_INVESTIGATOR

Nermin OLGUN

SUB_INVESTIGATOR

Yasemin SAZAK

CONTACT

[email protected]

05414474944

About this study

In line with the randomization list, patients will be assigned to the intervention and control groups in line with the inclusion criteria. Pre-test data will be collected face-to-face in the intervention group in accordance with the data collection forms. After collecting the pre-test data, the patient will be allowed to rest for about 10 minutes, and then COPD training will be given to the patient in a single session lasting about 45-50 minutes in line with the training booklet and by evaluating the pre-test data. The education booklet will be given to the patient. On the 3rd day, the first session of motivational interview will be held. On the 5th day and 7th day and 15th day, motivational interview sessions will continue with the patients. During the motivational interview, patients will be supported in line with the training booklet. On the 30th day, the patient will be interviewed face-to-face and post-test data will be collected.

Patients in the control group will be interviewed and no intervention will be made after the pre-tests are applied. Patients in the control group will continue their routine controls. In the final test (1st month), an appointment date will be set with the patient and the final test data will be collected face-to-face.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of COPD for at least 6 months
  • Admitted to the chest clinic
  • No communication problems
  • Patients who volunteered to participate in the study.

Exclusion criteria

  • In the period of exacerbation
  • Uncooperative due to dyspnea
  • With a malignant disease
  • Patients with a confirmed diagnosis of psychiatric illness

Treatment and study plan

Experimental: Education-based motivational interviewing Group

Behavioral

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Primary outcomes

  1. Morisky 8-item Medication Adherence Scale

    Time frame: 0 days

    It is a scale that assesses self-reported medication use behaviors of the patient. It consists of eight questions. A validation study in Turkish was conducted by Oğuzülgen et al. in 2014. While the first seven questions are answered as "yes/no", the eighth question is answered on a five-point Likert scale as "never/rarely", "sometimes", "sometimes", "usually" and "always". Morisky 8-item medication adherence scale is calculated between 0-8 points.

  2. Morisky 8-item Medication Adherence Scale

    Time frame: 30 days

    It is a scale that assesses self-reported medication use behaviors of the patient. It consists of eight questions. A validation study in Turkish was conducted by Oğuzülgen et al. in 2014. While the first seven questions are answered as "yes/no", the eighth question is answered on a five-point Likert scale as "never/rarely", "sometimes", "sometimes", "usually" and "always". Morisky 8-item medication adherence scale is calculated between 0-8 points.

  3. Self-care Agency Scale

    Time frame: 0 days

    The scale was developed by Kearney and Fleischer and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. In Nahcivan's study, the Cronbach's alpha coefficient of the scale was found to be 0.92. This scale, in which individuals self-assess their ability or power to perform self-care actions, consists of 35 items. The maximum score to be obtained from the scale is 140. As the score obtained from the scale increases, the self-care power of the patients also increases.

  4. Self-care Agency Scale

    Time frame: 30 days

    The scale was developed by Kearney and Fleischer and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. In Nahcivan's study, the Cronbach's alpha coefficient of the scale was found to be 0.92. This scale, in which individuals self-assess their ability or power to perform self-care actions, consists of 35 items. The maximum score to be obtained from the scale is 140. As the score obtained from the scale increases, the self-care power of the patients also increases.

Study contacts

Contact information is provided by the study sponsor or research team.

Yasemin SAZAK

CONTACT

[email protected]

541 447 49 44

Sponsors and collaborators

Lead sponsor

Kahramanmaraş İstiklal University

Other

Registry information

Official study title

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 13, 2024
Registry last updated
Dec 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.